Logo-apb
Adv Pharm Bull. 2021;11(2): 212-223. doi: 10.34172/apb.2021.025
PMID: 33880343        PMCID: PMC8046397

Review Article

Main Approaches to Enhance Radiosensitization in Cancer Cells by Nanoparticles: A Systematic Review

Behnaz Babaye Abdollahi 1,2,3 ORCID, Reza Malekzadeh 2, Fatemeh Pournaghi Azar 4 ORCID, Fatemeh Salehnia 5, Ali Reza Naseri 6, Marjan Ghorbani 7 ORCID, Hamed Hamishehkar 1 ORCID, Ali Reza Farajollahi 1,2,6 * ORCID

Cited by CrossRef: 3


1- Bauri S, Tripathi S, Choudhury A, Mandal S, Raj H, Maiti P. Nanomaterials as Theranostic Agents for Cancer Therapy. ACS Appl Nano Mater. 2023;6(23):21462 [Crossref]
2- Babaye Abdollahi B, Ghorbani M, Hamishehkar H, Malekzadeh R, Farajollahi A. Synthesis and characterization of actively HER-2 Targeted Fe3O4@Au nanoparticles for molecular radiosensitization of breast cancer. Bioimpacts. 2023;13(1):17 [Crossref]
3- Gharibkandi N, GieraƂtowska J, Wawrowicz K, Bilewicz A. Nanostructures as Radionuclide Carriers in Auger Electron Therapy. Materials. 2022;15(3):1143 [Crossref]
4- Jain S, Nagainallur Ravichandran S, Murali Kumar M, Banerjee A, Sun-Zhang A, Zhang H, Pathak R, Sun X, Pathak S. Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review. Cancer Biology & Therapy. 2024;25(1) [Crossref]
5- Paiva Barbosa V, Bastos Silveira B, Amorim dos Santos J, Monteiro M, Coletta R, De Luca Canto G, Stefani C, Guerra E. Critical appraisal tools used in systematic reviews of in vitro cell culture studies: A methodological study. Research Synthesis Methods. 2023;14(6):776 [Crossref]